Sep 22, 2026 07:30AM
Sep 22, 2026 07:30AM
Sep 9, 2026 07:33AM
Aug 28, 2026 07:30AM
Aug 28, 2026 07:30AM
Aug 27, 2026 04:09PM
Aug 27, 2026 04:09PM Kazia Therapeutics Limited Announces Proposed Public Offering
Aug 27, 2026 04:01PM
Aug 27, 2026 04:01PM
Jul 28, 2026 07:30AM
Jul 28, 2026 07:30AM
Jun 2, 2026 07:30AM
Jun 2, 2026 07:30AM
May 26, 2026 07:30AM Kazia Therapeutics expands breast cancer trial enrollment to 36 patients
May 26, 2026 07:30AM
Apr 15, 2026 08:01AM
Apr 15, 2026 08:00AM
Apr 15, 2026 02:24AM
Apr 13, 2026 05:07PM
Apr 13, 2026 05:05PM
Jan 30, 2026 08:00AM Kazia Therapeutics reports preclinical data for cancer drug NDL2
Jan 30, 2026 08:00AM
Jan 27, 2026 08:00AM
Jan 27, 2026 08:00AM
Dec 10, 2025 08:03AM
Dec 10, 2025 08:00AM
Nov 19, 2025 09:46AM
Nov 18, 2025 04:15PM Kazia Therapeutics reports complete response in breast cancer patient
Nov 18, 2025 04:15PM
Oct 28, 2025 06:43AM
Oct 27, 2025 07:16AM
Oct 27, 2025 07:15AM
Oct 7, 2025 08:33AM
Oct 7, 2025 08:30AM
Oct 2, 2025 08:31AM Kazia reports 86% tumor reduction in single breast cancer patient case
Oct 2, 2025 08:30AM
Oct 1, 2025 09:21AM
Sep 11, 2025 08:01AM
Sep 11, 2025 08:00AM
Jul 9, 2025 08:00AM
Jul 9, 2025 08:00AM
Jun 11, 2025 08:00AM Kazia Therapeutics (KZIA) Announces Transformative Preclinical Data Demonstrating Paxalisib's Potential to Overcome Immunotherapy Resistance in Triple-Negative Breast Cancer
Jun 11, 2025 08:00AM
Jun 5, 2025 08:00AM
May 15, 2025 08:00AM
Mar 31, 2025 07:31AM
Mar 31, 2025 07:30AM
Feb 20, 2025 08:46AM
Feb 20, 2025 08:46AM Kazia Therapeutics and the Hebrew University of Jerusalem Receives a Grant from The Michael J. Fox Foundation to Evaluate the Therapeutic Potential of Paxalisib as a Treatment for Parkinson's Disease
Jan 30, 2025 07:31AM

334,272 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All